PERSISTENCE OF MEASLES ANTIBODY TWO YEARS AFTER REVACCINATION BY AEROSOL OR SUBCUTANEOUS ROUTES
- 1 December 2000
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in The Pediatric Infectious Disease Journal
- Vol. 19 (12), 1211-1213
- https://doi.org/10.1097/00006454-200012000-00021
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trialThe Lancet, 2000
- Response to measles revaccination among Bolivian school-aged childrenTransactions of the Royal Society of Tropical Medicine and Hygiene, 1997
- Altenative Routes of Measles Immunization: a ReviewBiologicals, 1997
- La vacunación antisarampionosa en México por el método de aerosolSalud Publica de Mexico, 1997
- An Evaluation of Measles Revaccination Among School-entry-aged ChildrenPediatrics, 1996
- Serologic status and measles attack rates among vaccinated and unvaccinated children in rural SenegalThe Pediatric Infectious Disease Journal, 1995
- Detection of measles, mumps, and rubella antibodies in saliva using antibody capture radioimmunoassayJournal of Medical Virology, 1993
- Measles Antibody: Reevaluation of Protective TitersThe Journal of Infectious Diseases, 1990
- Hemagglutination by Measles Virus. 4. A Simple Procedure for Production of High Potency Antigen for Hemagglutination-Inhibition (HI) TestsExperimental Biology and Medicine, 1962